2018 Glaucoma Research Update: Andrew Huberman Lab, Part 2 

Andrew Huberman, PhD is a principal investigator in the Catalyst for a Cure consortium funded by Glaucoma Research Foundation in San Francisco, CA. Catalyst for a Cure brings together scientists from different backgrounds to work collaboratively to understand glaucoma and find ways to improve treatment and ultimately cure this blinding disease. The Huberman laboratory at Stanford University School of Medicine seeks to understand how the retinal and brain circuits that underlie vision wire up during development and to develop new strategies to monitor, prevent, and treat retinal ganglion cell loss in glaucoma. Learn more at www.glaucoma.org/research